Hangzhou Alltest Biotech (688606.SH): Net profit for the fiscal year 2024 was 304 million yuan, a year-on-year increase of 68.18%.

Hangzhou Alltest Biotech (688606.SH) released its 2024 annual performance report, stating that during the reporting period, the company achieved operating income of 870 million yuan, a year-on-year increase of 15.25%; net profit attributable to the owners of the parent company was 304 million yuan, a year-on-year increase of 68.18%; net profit attributable to the owners of the parent company after deducting non-recurring gains and losses was 239 million yuan, a year-on-year increase of 62.92%; basic earnings per share were 3.83 yuan/share.